Tandem Diabetes Care | TNDM - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Abbott USD 1.74B 2.94M 2026-03
Accuray USD 100K 1000 2024-09
Align Technology USD 71.62M 1000 2026-06
AtriCure USD 50.64M 7K 2026-06
Baxter International USD 517M 549K 2026-06
Becton, Dickinson and Co. USD 370.59M 95.05M 2026-06
Boston Scientific USD 1.48B 2.66M 2025-12
Cooper Companies USD 195.11M 14K 2026-03
Dexcom USD 377.4M 8.5M 2026-06
Edwards Lifesciences USD 577M 3.7M 2026-03
Eli Lilly USD 943.5M 3.33M 2026-03
Globus Medical USD 135.67M 611K 2026-03
ICU Medical USD 24.99M 305K 2026-03
Inogen USD 23K 0 2023-12
Insulet USD 69.35M 87K 2026-06
Integra LifeSciences USD 77.78M 39K 2026-06
Intuitive Surgical USD 354.16M 1.01M 2026-06
J&J USD 2.41B 1.35M 2026-03
Medtronic USD 1.28B 3.19M 2026-03
Merit Medical Systems USD 59.71M 55K 2026-06
Orthofix International USD 39.83M 315K 2025-12
Roche Holding CHF 796.77M 1.15M 2026-06
Stryker USD 383.4M 416K 2026-06
Tandem Diabetes Care USD 69.54M 1.04M 2026-06
Teleflex USD 44.26M 70K 2026-03
Zimmer Biomet Holdings USD 193.4M 2.1M 2026-06